LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 2.66 | 84.90 | 750 | 285 | 2.6248 | 2.4705 | MN20160318_Q02 | M11 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.1 | 2.66 | 84.90 | 752 | 285 | 2.6318 | 2.4757 | MN20160318_Q02 | N14 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 2.66 | 84.90 | 764 | 285 | 2.6738 | 2.5073 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 2.66 | 84.90 | 781 | 285 | 2.7333 | 2.5517 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 2.66 | 84.90 | 783 | 285 | 2.7403 | 2.5569 | MN20160318_Q02 | I09 |